Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi-Reference-Cited by-同舟云学术

Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi

Published:2020-06-15 Issue:12 Volume:55 Page:2350-2353
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Merli Michele^ORCID,Luminari Stefano,Farina Lucia,Cocito Federica,Defrancesco Irene,Gini Guido,Arcari Annalisa,Scapinello Greta,Gentile Massimo,Goldaniga Maria,Loseto Giacomo,Cencini Emanuele^ORCID,Greco Antonino,Molinari Anna Lia,Ferrario Andrea,Bianchi Benedetta,Mora Barbara,Bertù Lorenza,Saturni Vincenzo,Bergamini Fabio,Fabbri Nicole,Rossi Francesca Gaia,Bolis Silvia,Passamonti Francesco,Arcaini Luca

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-0967-5.pdf

Reference12 articles.

1. Cheson BD, Rummel MJ. Bendamustine: rebirth of an old drug. J Clin Oncol. 2009;27:1492–501. 2009/02/17

2. Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, et al. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 2013;381:1203–10.

3. Flinn IW, van der Jagt R, Kahl B, Wood P, Hawkins T, MacDonald D, et al. First-line treatment of patients with indolent non-Hodgkin lymphoma or mantle-cell lymphoma with bendamustine plus rituximab versus R-CHOP or R-CVP: results of the BRIGHT 5-year follow-up study. J Clin Oncol. 2019;37:984–91.

4. Rummel M, Kaiser U, Balser C, Stauch M, Brugger W, Welslau M, et al. Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial. Lancet Oncol 2016;17:57–66.

5. Montoto S, Corradini P, Dreyling M, Ghielmini M, Kimby E, López-Guillermo A, et al. Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party. Haematologica 2013;98:1014 LP–1021.